Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma
Clinical trial NCT05011227 · UNKNOWN
Trial details
- NCT number
- NCT05011227
- Sponsor
- Eye & ENT Hospital of Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-10
- Primary completion
- 2025-08-10
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.